International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation

Current Medical Research and Opinion

Volumn 30, Issue 12, 2014, Pages 2437-2442

  Nelson, Winnie W ^a   Desai, Sunita ^b   Damaraju, C V ^c   Lu, Lang ^c   Fields, Larry E ^c   Wildgoose, Peter ^c   Schein, Jeff R ^a  

^a Health Economics and Outcomes Research Janssen Scientific Affairs   (United States)

^b S2 Statistical Solutions Inc   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

International normalized ratio; Nonvalvular atrial fibrillation; Stabilization; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADOLESCENT; ADULT; AGED; ATRIAL FIBRILLATION; BLOOD; COMPLICATION; DRUG ADMINISTRATION; FACTUAL DATABASE; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LONGITUDINAL STUDY; MALE; MIDDLE AGED; STROKE; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; DATABASES, FACTUAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; STROKE; TREATMENT OUTCOME; UNITED STATES; WARFARIN; YOUNG ADULT;

EID: 84914160420     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2014.957822     Document Type: Article

References (9)

1. Goldstein LB, Bushnell CD, Adams RJ, et al. American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, Council for High Blood Pressure Research, Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:517-84.
2. Erratum in: Stroke 2011;42:e26
3. Heneghan C, Tyndel S, Bankhead C, et al. Optimal loading dose for the initiation of warfarin: a systematic review. BMC Cardiovasc Disord 2010;10:18
4. Mahtani KR, Heneghan CJ, Nunan D, et al. Optimal loading dose of warfarin for the initiation of oral anticoagulation. Cochrane Database Syst Rev 2012;12:CD008685
5. Nutescu E, Chuatrisorn I, Hellenbart E. Drug and dietary interactions of warfarin and novel oral anticoagulants: an update. J Thromb Thrombolysis 2011;31:326-43
6. Witt DM, Delate T, Clark NP, et al.; Warfarin Associated Research Projects and other EnDeavors (WARPED) Consortium. Outcomes and predictors of very stable INR control during chronic anticoagulation therapy. Blood 2009;114:952-6
7. Rombouts EK, Rosendaal FR, van der Meer FJ. Subtherapeutic oral anticoagulant therapy: frequency and risk factors. Thromb Haemost 2009;101:552-6
8. Rosendaal FR, Cannegieter SC, van der Meer FJ, et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993;69:236-9
9. Nelson WW, Choi JC, Vanderpoel J. Impact of comorbidities and patient characteristic on international normalized ratio control over time in patients with nonvalvular atrial fibrillation. Am J Cardiol 2013;112:509-12